Individualized Cancer Therapy, Future Approaches

Author(s): Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen, Nagendra Sastry Yarla

Journal Name: Current Pharmacogenomics and Personalized Medicine
Formerly Current Pharmacogenomics

Volume 16 , Issue 2 , 2018

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Cancer is a series of different disease (>200 different sub-types) with an identical feature of unlimited growth, invasive and multi-step/multi-level metastasis processes.

Objective: Individualized cancer therapies/personalized cancer therapies will undergo a dramatic evolution to cope with this disease diversity and a complexity of tumor genes/biomarkers.

Methods: The next generation of personalized cancer therapy must simultaneously contain information of pharmacology (drug sensitivity or drug combination), oncology (tumor etiopathological information), computational network (predictive of cancer risks and therapeutic efficacy), toxicology (adverse side-effects and human mortality), artificial intelligence and patient’s desire (decision-aid), especially technology merge.

Results: Future multi-functional approach is inevitable. After all, multi-functional personalized cancer therapy (collective and balanced regime/paradigms) might take formation in the future.

Conclusion: A reliable, safe, effective and collective platform can be established through further scientific and technical approaches in the clinic.

Keywords: Individualized cancer therapy, personalized medicine, pharmacology, neoplasm pathology, drug combinations, neoplasm metastasis, mathematics, computational network, decision aid.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 12 November, 2018
Page: [156 - 163]
Pages: 8
DOI: 10.2174/1875692116666180821095434

Article Metrics

PDF: 27